Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sanbei Zhuhan Capsule** is an oral traditional Chinese medicine capsule being developed for **obstructive sleep apnea hypopnea syndrome**, specifically patients classified in traditional Chinese medicine as having a phlegm-and-blood-stasis pattern. It was originally developed by Dongyang Baorentang Pharmaceutical's Beijing Technology Branch. A completed multicenter, randomized, double-blind, placebo-controlled Phase III study evaluated its efficacy and safety, using apnea-hypopnea index response at Week 4 as the primary efficacy endpoint. Its specific botanical composition and molecular mechanism of action were not identified in the available public trial records.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sanbei Zhuhan Capsule.